Monitoring of minimal residual disease by quantitative reverse transcriptase-polymerase chain reaction for AML1-MTG8 transcripts in AML-M2 with t(8;21)

Blood

Volumn 88, Issue 10, 1996, Pages 3704-3709

  Tobal, Khalid ^a   Liu Yin, John A ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTARABINE; DAUNORUBICIN; ETOPOSIDE; TIOGUANINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; AGED; ARTICLE; BONE MARROW TRANSPLANTATION; CHROMOSOME TRANSLOCATION 21; CHROMOSOME TRANSLOCATION 8; CLINICAL ARTICLE; FEMALE; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MINIMAL RESIDUAL DISEASE; PRIORITY JOURNAL; QUANTITATIVE DIAGNOSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0029824952     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v88.10.3704.bloodjournal88103704     Document Type: Article

References (16)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposed revised criteria for the classification of the acute myeloid leukemia. Ann Intern Med 103:620, 1985
2. Erickson P, Gao J, Chang KS, Look T, Whisenant E, Raimondi S, Lasher R, Trujillo J, Rowley J, Drabkin H: Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript, AML1/ETO, with similarity to Drosophila segmentation gene, runt. Blood 80:1825, 1992
3. Kusec R, Laczika K, Knobl P, Friedl J, Greinix H, Kahls P, Linkesch W, Schwarzinger I, Mitterbauer G, Purtscher B, Haas OA, Lechner K, Jaeger U: AML1/ETO fusion mRNA can be detected in remission blood samples of all patients with t(8;21) acute myeloid leukemia after chemotherapy or autologous bone marrow transplantation. Leukemia 8:735, 1993
4. Nucifora G, Larson RA, Rowley JD: Persistence of the 8;21 translocation in patients with acute myeloid leukemia type M2 in long term remission. Blood 82:712, 1993
5. Saunders MJ, Tobal K, Liu Yin JA: Detection of t(8;21) by reverse transcriptase polymerase chain reaction in patients in remission of acute myeloid leukaemia type M2 after chemotherapy or bone marrow transplantation. Leuk Res 18:891, 1994
6. Cross NCP, Lin F, Chase A, Bungey J, Hughes TP, Goldman JM: Competitive polymerase chain reaction to estimate the number of BCR-ABL transcripts in chronic myeloid leukemia patients after bone marrow transplantation. Blood 82:1929, 1993
7. Lin F, van Rhee F, Goldman JM, Cross NCP: Kinetics of increasing BCR-ABL transcript numbers in chronic myeloid leukemia patients who relapse after bone marrow transplantation. Blood 87:4473, 1996
8. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156, 1987
9. Cross NCP, Hughes TP, Feng L, O'Shea P, Bungey J, Marks DI, Ferrant A, Martial P, Goldman JM: Minimal residual disease after allogeneic bone marrow transplantation for chronic myeloid leukaemia in first chronic phase: Correlations with acute graft-versus-host disease and relapse. Br J Haematol 84:67, 1993
10. Tighe J, Calabi F: Alternative out-of-frame runt/MTG8 transcripts are encoded by the derivative (8) chromosome in the t(8;21) of acute myeloid leukemia M. Blood 84:2115, 1994
11. van der Locht LTF, Smetsers TFCM, Wittebol S, Raymakers RAP, Mensink EJBM: Molecular diversity in AML1/ETO fusion transcripts in patients with t(8;21) positive acute myeloid leukaemia. Leukemia 8:1780, 1994
12. Saunders MJ, Tobal K, Keeney S, Liu Yin JA: Expression of diverse AML1/MTG8 transcripts is a consistent feature in acute myeloid leukemia with t(8:21) irrespective of disease phase. Leukemia 10:1139, 1996
13. Asou H, Tashiro S, Hamamoto K, Otsuji A, Kita K, Kamada N: Establishment of a human acute myeloid leukemia cell line (Kasumi-1 ) with 8;21 chromosome translocation. Blood 77:2031, 1991
14. Clackson T, Gussow D, Jones PT: General application of PCR to gene cloning and manipulation, in McPherson MJ, Quirke P, Taylor GR (eds): PCR: A Practical Approach. New York, NY, Oxford 1991, p 207
15. Wheatley K, Burnett A, Goldstone A, Hann I, Stevens R, Rees J, Gray R: A simple robust and highly predictive prognostic index for the determination of risk directed therapy in acute myeloid leukaemia (AML) derived from the united kingdom medical research council (MRC) AML 10 trial. Blood 86:598a, 1995 (abstr. suppl 1)
16. Swirsky DM, Li YS, Matthews JG, Flemans RJ, Rees JKH, Hayhoe FGJ: 8;21 translocation in acute granulocytic leukaemia: Cytological, cytochemical and clinical features. Br J Haematol 56:199, 1984